Descrizione del progetto
Una nuova emulsione di omega-3 per scopi medici specifici
Gli acidi grassi omega-3 svolgono un ruolo fondamentale per la salute delle membrane cellulari e per il benessere generale dell’uomo, compresa la salute del cervello, del cuore e degli occhi. Il nostro organismo non è in grado di produrli e la maggior parte delle persone non ne assume a sufficienza nella propria dieta. Alcuni studi suggeriscono che gli acidi grassi omega-3 possono essere utili anche ai pazienti oncologici sottoposti a chemioterapia, riducendo le complicanze secondarie correlate al cancro e al suo trattamento. Il progetto LIFEOMEGA, finanziato dall’UE, sosterrà la PMI spagnola Solutex nella preparazione del suo integratore alimentare di omega-3 (EPA) altamente concentrato ed emulsionato per la produzione e la commercializzazione su scala industriale. L’emulsione può essere utilizzata come integratore orale a sé stante e come potenziale complemento di altre formulazioni liquide per scopi medici specifici.
Obiettivo
The objective of the project is the industrial and market development of a high concentrated Omega3 EPA nutritional product addressed to improve the health of cancer patients.
LIFEOMEGA-cancer can be considered one chemotherapy essential nutrient co-adjuvant by overcoming:
1. The deficit of necessary level essential Omega3 EPA fatty acid by one efficient concentration and daily dosage (min 2.2 g EPA per day)
2. On a convenient way for the patient overcoming unpleasant fishy taste and with one unique delivery form
The product is protected by IP and constitutes a unique product and solution, not present in the market. Moreover, it is flavourized, and being an emulsion, it can be conveniently delivered in other liquids. These features make the product a complete breakthrough Medical Food in the essential nutrition market, both in Europe and in the USA.
Cancer patients receiving chemotherapy will be highly benefitted with LIFEOMEGA product; they can have their treatments (as cancer chemo/radiotherapy treatments) outcomes improved, their length of hospital stay reduced, and their quality of life during and after treatment increased. The high convenience allows the consumption of fewer dosages to achieve the targeted Omega3 levels.
LIFEOMEGA has a great potential, as it is estimated that cancer patients recieving chemotherapy unfortunately won't be less than 1 millon / year during the next 11 years, in USA, Spain, France, Germany, UK and Italy.
Campo scientifico
Programma(i)
- H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
- H2020-EU.3.2.4. - Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy
- H2020-EU.3.2.1. - Sustainable agriculture and forestry
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.2.2. - Sustainable and competitive agri-food sector for a safe and healthy diet
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEINST-2-2016-2017
Meccanismo di finanziamento
SME-2 - SME instrument phase 2Coordinatore
28108 Alcobendas Madrid
Spagna
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.